Dapagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Dapagliflozin, Sitagliptin & Metformin Hydrochloride (ER) Tablets

Sitagil-DM

Sitagil DM is a powerful triple-action formulation designed for the effective management of Type 2 Diabetes Mellitus. This combination of Dapagliflozin, Sitagliptin, and Metformin Hydrochloride (Extended Release) helps improve glycemic control by targeting multiple pathways involved in blood sugar regulation. Sitagil DM not only helps reduce blood glucose levels but also supports better insulin sensitivity and overall metabolic health, making it a comprehensive treatment option for diabetic patients.

Key Ingredients

Dapagliflozin (10 mg): An SGLT2 inhibitor that lowers blood sugar by preventing glucose reabsorption in the kidneys and promoting glucose excretion through urine.

Sitagliptin: A DPP-4 inhibitor that increases incretin levels in the body, stimulating insulin release and decreasing glucose production by the liver.

Metformin Hydrochloride (ER) (500 mg): A biguanide that reduces glucose absorption from food, limits hepatic glucose production, and enhances the body’s sensitivity to insulin.

Benefits

Comprehensive Glycemic Control: Combines three complementary mechanisms to effectively lower and maintain stable blood sugar levels in Type 2 Diabetes.

Improved Insulin Sensitivity: Metformin and Sitagliptin work together to enhance the body’s natural insulin response.

Cardiovascular & Metabolic Support: Dapagliflozin helps reduce cardiovascular risks and promotes mild weight reduction through glucose elimination.

Convenient Extended-Release Formulation: Offers once-daily dosing for better compliance and long-term management of diabetes.

Usage Instructions

Take one tablet of Sitagil DM daily with meals or as prescribed by your healthcare professional. Swallow the tablet whole with water. Follow a balanced diet and regular exercise routine to achieve optimal blood sugar control.

Side Effects

Common side effects of Sitagil DM (Dapagliflozin, Sitagliptin & Metformin Hydrochloride ER Tablets) may include mild nausea, headache, urinary tract infection, increased urination, or stomach discomfort. Rarely, hypoglycemia, dehydration, or lactic acidosis may occur. Seek medical advice if you experience any severe or persistent symptoms.

General Information

Globus Labs brings you WHO-GMP–certified, high-quality Dapagliflozin, Sitagliptin & Metformin Hydrochloride sourced from reputed pharmaceutical manufacturers. SITAGIL-DM is formulated to deliver safe, potent, and clinically trusted support.

Grow With Us

Partner With Confidence

Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.